Federal regulators issued a nationwide recall for three lots of American Regent epinephrine injection USP 30 mg/ 30 mL due to a lack of sterility assurance and the presence of particulate matter that poses serious clinical risks, according to the FDA. The contamination and sterility issues carry potential hazards for patients, including the risk of particulate matter causing blockage and clotting in blood vessels during administration.
Supply Chain Stress and Compounding Adjustments
To combat ongoing supply chain issues affecting essential medicines, the FDA announced temporary compounding rules for neonatal starter parenteral nutrition products, according to the agency. These adjustments aim to maintain availability for vulnerable patient populations while manufacturers navigate production hurdles.
Simultaneously, drug availability challenges continue to impact acute care settings.
Regulatory Enforcement and Policy Shifts
The HHS Office of Minority Health abruptly terminated more than half of its existing grants for not aligning with current agency priorities, according to a report by NOTUS. The agency’s redirected focus centers on addressing the root causes of infertility and promoting exercise.
In reproductive health litigation, the next frontier in the battle over the abortion medication mifepristone involves a case brought by Louisiana challenging FDA oversight on telemedicine and mail-order access.
Public Health Interventions and Clinical Trials
Public health workers in Pennsylvania are turning to word-of-mouth advertising and pop-up vaccination clinics to reach targeted communities amid a large measles outbreak, according to the Washington Post. Field teams utilize localized engagement strategies to boost immunization rates where traditional outreach falls short.
In pharmaceutical research, Novartis announced that its phase III lipoprotein(a) HORIZON trial found pelacarsen, an investigational antisense oligonucleotide, did not meet the study’s primary endpoints.
Did You Know? Research highlighted by CIDRAP indicates that many individuals carrying a reported penicillin allergy may safely tolerate the antibiotic after formal clinical evaluation and skin testing.
Frequently Asked Questions
Why were the American Regent epinephrine lots recalled?
The FDA recalled three lots of American Regent epinephrine injection USP 30 mg/ 30 mL due to a lack of sterility assurance and the presence of particulate matter that could cause blood vessel blockage and clotting.
What is the focus of the HHS Office of Minority Health grant restructuring?
According to NOTUS, the office terminated more than half of its existing grants because they did not align with current agency priorities focused on addressing the root causes of infertility and promoting exercise.
Where is the legal challenge against FDA mifepristone rules heading?
According to The Hill, a lawsuit brought by Louisiana challenging FDA telemedicine and mail-order access for mifepristone will be heard by a three-judge panel on the 5th U.S.
Explore our latest health policy updates or subscribe to our daily newsletter for breaking healthcare news and regulatory analysis.
Related reading